racial disparities Covid-19 Archives

Photo taken on Aug. 23, 2021 shows the U.S. Food and Drug Administration in Silver Spring, Maryland, the United States. The U.S. Food and Drug Administration FDA on Monday granted full approval to the Pfizer/BioNTech COVID-19 vaccine for people age 16 and older. (Photo by Ting Shen/Xinhua via Getty Images)

FDA Panel Backs Pfizer Booster for Seniors, High-Risk Groups

Published on September 20, 2021August 8, 2025

By Maggie Fox and Madeline Holcombe, Advisers to the US Food and Drug Administration on Friday voted unanimously to recommend emergency use authorization of Pfizer’s booster shot six months after full vaccination in Americans 65 and older as well as those at high risk of severe Covid-19. That vote came after the group had first